pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,247 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,318
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07566702: Effect of Neuromuscular Electrical Stimulation on Muscle Mass in ECMO Patients

    Sponsor: Cairo University. Phase: NA. Conditions: Muscle Mass Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06628453: CGM for Management of Type 2 Diabetes in Pregnancy

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM), Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07705737: Rademikibart IV for Acute Asthma and COPD Exacerbation

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute, COPD Exacerbation Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06994637: Effects of Liquid Hourglass and Spiky Ball on Pain, Fear, Anxiety and Emotional Manifestations

    Sponsor: Hakkari Universitesi. Phase: NA. Conditions: Pain, Anxiety and Fear, Procedural Anxiety, Procedural Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07503951: Cognitive Behavior Therapy in Psychiatric Inpatient Care

    Sponsor: Region Stockholm. Phase: NA. Conditions: Depression, Anxiety Disorders, Psychiatric Inpatients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04207931: Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

    Sponsor: Wake Forest University Health Sciences. Phase: PHASE4. Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07626502: Immediate vs Delayed Postpartum Implanon-NXT

    Sponsor: Assiut University. Phase: . Conditions: Delayed and Secondary Postpartum Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06776653: Impact of a Snoezelen Element on Anxiety in Patients During Oral Care: A Real-Life Study at Nantes University Hospital

    Sponsor: Nantes University Hospital. Phase: . Conditions: Odontologic Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07108153: Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

    Sponsor: Sionna Therapeutics Inc.. Phase: PHASE2. Conditions: Cystic Fibrosis (CF)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06536894: Fibromyalgia Syndrome on Anthropometric and Ultrasonographic Measurements in Obstructive Sleep Apnea Syndrome

    Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Fibromyalgia Syndrome, Obstructive Sleep Apnea Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05164094: A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

    Sponsor: ModernaTX, Inc.. Phase: PHASE1. Conditions: Epstein-Barr Virus Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07362056: Implementing Suicide Prevention Into Primary Care in Nepal

    Sponsor: Yale University. Phase: NA. Conditions: Suicide, Primary Care

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06957756: A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Hepatic Insufficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07316556: Post-Marketing Surveillance of Vliwazell® Prowound Dressing

    Sponsor: Lohmann & Rauscher. Phase: . Conditions: Acute and Chronic Wounds

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07436156: SUMMIT RISE Study of Acute Ischemic Stroke Patients

    Sponsor: Route 92 Medical, Inc.. Phase: PHASE4. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05689151: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

    Sponsor: Pfizer. Phase: . Conditions: Atopic Dermatitis, Eczema

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03016156: Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

    Sponsor: St. Jude Children's Research Hospital. Phase: NA. Conditions: Retinoblastoma, Cataracts Infantile, Glaucoma, Congenital, Leucocoria

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01500551: Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04800029: Telehealth to Improve Prevention of Suicide (TIPS)

    Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Suicide Risk

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07595302: Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain

    Sponsor: Montefiore Medical Center. Phase: PHASE4. Conditions: Pelvic Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07692802: Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes

    Sponsor: CHA University. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07337902: Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Crohn's Disease (CD), Dysmenorrhea Primary

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06850402: Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cervical Cancer, HIV

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07634653: Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Leukemia, Acute Leukemia, Acute Lymphoid Leukemia, Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07232537: An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

    Sponsor: Bayer. Phase: . Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06258837: Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils

    Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Otolaryngological Disease, Obstructive Sleep Apnea

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07460882: The Impact of Low Sodium Salt Substitute Use on Serum Potassium Levels Among Patients With Hypertension

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07421323: Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection

    Sponsor: Alexandria University. Phase: NA. Conditions: Neonatal Sepsis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06198023: Targeting Social Function in Anxiety and Eating Disorders

    Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Atypical Anorexia Nervosa, Purging (Eating Disorders), Other Specified Feeding or Eating Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder (GAD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03747120: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: HER2-positive Breast Cancer, Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06134882: OUD Smartphone Services

    Sponsor: Western Michigan University. Phase: NA. Conditions: Opioid-Related Disorders, Drug Abuse

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07216482: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Hyperlipidemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07470450: Acute and Chronic Effects of Combined Training on BP in Hypertensives

    Sponsor: Federal University of Rio Grande do Sul. Phase: NA. Conditions: Dynamic Strength Exercise Session, Isometric Strength Exercise Session, Combined Exercise Session, Control Session (CON), Dynamic Strength Training, Combined Strength Training, Isometric Strength Training

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07417891: Ketogenic Diet to Reduce Osteoarthritis Pain in MCI

    Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Osteoarthritis (OA) of the Hip, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder, Osteoarthritis, Mild Cognitive Impairment, MCI, Mild Cognitive Impairment (MCI), Dementia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06045975: Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: HCC - Hepatocellular Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07437157: The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register

    Sponsor: Chinese University of Hong Kong. Phase: . Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Type 2 Diabetes (T2DM)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05467657: Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke

    Sponsor: Neuron, Spain. Phase: NA. Conditions: Transcranial Magnetic Stimulation, Stroke, Motor Learning

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06212557: KIOS Mobile App Evaluation

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: NA. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01753557: Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Hepatitis C (CHC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06430957: OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

    Sponsor: Kırıkkale University. Phase: . Conditions: Obstructive Sleep Apnea Risk Management, Postoperative Complications, Dental Caries Under General Anesthesia, Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07030101: A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

    Sponsor: EMS. Phase: PHASE3. Conditions: Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491601: PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

    Sponsor: Nicolas Schlegel. Phase: NA. Conditions: Postoperative Hypoparathyroidism, Postsurgical Hypoparathyroidism, Hypoparathyroidism Post-surgical

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07702981: Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

    Sponsor: University Hospital, Ioannina. Phase: . Conditions: Membranous Nephropathy, Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07484152: Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor

    Sponsor: University of Sao Paulo General Hospital. Phase: PHASE1. Conditions: Essential Tremor (ET)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07539233: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: EARLY_PHASE1. Conditions: Multiple Myeloma (MM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06504147: A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

    Sponsor: Oncoinvent Solutions AS. Phase: PHASE2. Conditions: Peritoneal Carcinomatosis, Ovarian Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06699849: Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

    Sponsor: CSL Behring. Phase: PHASE2. Conditions: Sickle Cell Disease Vaso-occlusive Crisis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05679349: Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

    Sponsor: Ronald Myers. Phase: NA. Conditions: Lung Carcinoma, Tobacco-Related Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01659749: Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria

    Sponsor: Emory University. Phase: NA. Conditions: Pregnancy, Phenylketonuria

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05886049: A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation, Secondary Acute Myeloid Leukemia

    full page →ctgov ↗
    ← prev
    page 90 of 105
    next →